The Portuguese pharmaceutical market has seen wide-ranging government interventions since the country’s financial crisis in 2011. Portugal’s economic reforms and international loan conditions prompted health sector reforms including reducing pharma expenditures, cutting healthcare professionals’ salaries and increasing co-payments.
In Portugal, as direct-to-consumer promotion of prescription drugs is not permitted, the boundaries between promotional information versus educational information are more distinct than in other countries, such as the United States. Promotional activities are conducted by the National Authority of Medicines and Health Products (INFARMED), and the presented information must be scientific, accurate and objective and not misleading.
Sign up to get the guides
Select the guides you wish to download